No Data
No Data
Calculating The Intrinsic Value Of Compugen Ltd. (NASDAQ:CGEN)
Truist Financial Maintains Compugen(CGEN.US) With Buy Rating
Compugen Ltd. (NASDAQ:CGEN) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Compugen's 2024 Results Highlight Clinical Progress and Financial Stability
Compugen's Earnings Call: A Cautiously Optimistic Outlook
Earnings Call Summary | Compugen(CGEN.US) Q4 2024 Earnings Conference